TIF organises the‘’1st International Informational Forum on New & Innovative Therapies for Haemoglobinopathies’’_12 December 2019

  In light of the rapid scientific developments in the field of thalassaemia and Sickle Cell Di...

Thalassaemia from ‘A’ to ‘Z’: A comprehensive e-glossary for patients with thalassaemia (2019)

The “Thalassaemia from A to Z” electronic glossary is a comprehensive, easy to use, educational tool...

FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease

  Global Blood Therapeutics, Inc. announced only a few hours ago that the U.S. Food and Drug Ad...

TIF by the side of thalassaemia patients in Syria

  The World Health Organisation (WHO) has contacted the Thalassaemia International Federation (...

      IS BETA – THALASSAEMIA OR SICKLE CELL DISEASE IN YOUR PIPELINE?   LEARN ABOUT PATIENTS’ EXPECT...